Supernus Pharmaceuticals | SUPN - Trade Debtors

Stock Price
51.23
Daily Change
1.86 3.77%
Monthly
-0.02%
Yearly
33.41%
Q1 Forecast
46.68

Supernus Pharmaceuticals reported $171.25M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Eisai JPY 224.06B 4.08B Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Pacira USD 115.27M 901K Sep/2025
Perrigo USD 644.4M 62.2M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Supernus Pharmaceuticals USD 171.25M 30.42M Sep/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025